STERIS provides products and services that support patient care with an emphasis on infection prevention.

STERIS

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Teleflex Incorporated

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Stryker Corporation

NATUS is a manufacturer of medium-voltage and low-voltage switchgear, substations, and automation cabinets. They provide planning, engineering, and turnkey project services in the electrical and automation sectors.

Metric
Company Name	STERIS	Teleflex Incorporated	Stryker Corporation	NATUS
Symbol		TFX	SYK
MSH ID	COM:CANTELMEDICAL	COM:TELEFLEX	COM:STRYKER	DE:NATUS
Market	PRIVATE	STOCKS	STOCKS	PRIVATE
Sector	Healthcare & Health Services	Healthcare	Healthcare	Capital Goods & Industrials
Industry	Medical Devices	Medical - Instruments & Supplies	Medical - Devices	Electrical Equipment
Country	US	US	US	DE
Stage	Post-IPO Debt
Employee Count		14.50K	52K
Website	cantelmedical.com	teleflex.com	stryker.com	natus.de
LinkedIn			stryker
Founders

Metric
Market Cap		10.39B	128.51B
Enterprise Value
Monthly Web Traffic	300.33K		1.16M
Web Traffic Growth	-0.25		0.10
Valuation
Raised Capital	285K

Metric
Revenue	2.97B	20.50B
Revenue (LTM)
Revenue (NTM)
Gross Profit	1.65B	13.06B
EBITDA	817.61M	4.95B
Operating Income	506.31M	3.89B
Net Income	356.33M	3.17B
EPS	7.58	8.34
Diluted EPS	7.53	8.25
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.56	0.64
Operating Profit Margin	0.17	0.20
EBITDA Margin	0.27	0.24
Net Profit Margin	0.12	0.16
Return on Equity	0.08	0.18
Return on Assets	0.05	0.09
Return on Capital Employed	0.07	0.13

COM:CANTELMEDICAL

STERIS

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	28.57	41.17
P/B Ratio	2.67	3.27
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	3.88	6.62
EV Multiple	12.17	24.94

Metric
Days Sales Outstanding	52.46	67.04
Days Payables Outstanding	36.11
Days Inventory Outstanding	175.30	241.76
Operating Cycle	229.78	304.64
Cash Conversion Cycle	198.55	302.23
Asset Turnover	0.40	0.55

Metric
Operating Cash Flow	510.64M	3.71B
Free Cash Flow	419.20M	3.14B
Cash Flow to Debt	0.32	0.34
Operating Cash Flow/Sales	0.18	0.18
Free Cash Flow Yield	0.03	0.02

Metric
Cash & Equivalents	222.85M	2.97B
Accounts Receivable	-15.76M	-175M
Inventory	626.22M	4.84B
Goodwill	2.91B	15.24B
Debt to Capitalization	0.30	0.51
Debt to Assets	0.29	0.27
Current Ratio	3.58	1.58
Quick Ratio	1.44	0.99

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01	0.00
R&D to Revenue	0.05	0.07
SG&A to Revenue